CHINA BIOTECH SERVICES HOLDINGS LIMITED China Biotech Services Holdings Limited Share Price
Equities
8037
BMG2152F1014
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.27 HKD | -5.26% |
|
+1.89% | -64.94% |
| Sales 2022 | 1.85B 237M 18.89B | Sales 2023 | 212M 27.09M 2.16B | Capitalization | 742M 94.77M 7.57B |
|---|---|---|---|---|---|
| Net income 2022 | 258M 32.96M 2.63B | Net income 2023 | -95M -12.14M -969M | EV / Sales 2022 | 0.59 x |
| Net cash position 2022 | 10.99M 1.4M 112M | Net Debt 2023 | 28.31M 3.62M 289M | EV / Sales 2023 | 3.63 x |
| P/E ratio 2022 |
4.29
x | P/E ratio 2023 |
-7.77
x | Employees | 169 |
| Yield 2022 |
0.87% | Yield 2023 |
-
| Free-Float | 35% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -5.26% | ||
| 1 week | +1.89% | ||
| Current month | -22.86% | ||
| 1 month | -16.92% | ||
| 3 months | -60.29% | ||
| 6 months | -63.51% | ||
| Current year | -64.94% |
1 week
0.25
0.33
1 month
0.250.39
Current year
0.250.80
1 year
0.251.08
3 years
0.252.64
5 years
0.252.64
10 years
0.122.85
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 0.27 | -5.26% | 635 000 |
| 26/04/24 | 0.285 | +1.79% | 120,000 |
| 25/04/24 | 0.28 | +7.69% | 195,000 |
| 24/04/24 | 0.26 | 0.00% | 30,000 |
| 23/04/24 | 0.26 | -1.89% | 85,000 |
Delayed Quote Hong Kong S.E., April 29, 2024 at 09:08 am
More quotes
China Biotech Services Holdings Ltd, formerly Rui Kang Pharmaceutical Group Investments Ltd, is an investment holding company principally engaged in the provision of medical health check services. The Company operates its business through six segments. The Medical and Health Related Services segment provides medical laboratory testing services and health check services. The Insurance Brokerage segment is engaged in the provision of brokerage services. The Immunotherapy segment provides tumor immune call therapy, immune cell storage and health management services. The Pharmaceutical Products segment is engaged in the manufacture, research and development, sale and distribution of health related and pharmaceutical products. The Securities segment is engaged in the trading of securities. The Others segment is engaged in the money lending business and provision of logistic services.
Calendar
08/05/2024
- Q1 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -64.94% | 35.07M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +11.62% | 29.59B | |
| -12.71% | 16.73B | |
| -2.28% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -0.16% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- 8037 Stock
